Why the study?
Increased LAVI is related to increased mortality in hemodialysis patients, prompting evaluation of its association with PWPT, a newly introduced electrocardiographic parameter.
Does prolonged P wave peak time predict increased left atrial volume index in hemodialysis patients?
Does prolonged P wave peak time predict increased left atrial volume index in hemodialysis patients?
A prolonged P wave peak time in lead D2 (≥60 ms) is independently associated with an increased left atrial volume index in hemodialysis patients, serving as a potential non-invasive marker for high risk.
May support PWPTD2 ≥60 ms as a non-invasive marker for increased LAVI in hemodialysis; hypothesis-generating and requires prospective validation.
OBJECTIVE: An increased left atrial volume index (LAVI) is related to increased mortality in hemodialysis patients. In the present study, we evaluated the association between the LAVI and the P wave peak time (PWPT), a newly introduced electrocardiographic parameter, in hemodialysis patients. METHODS: The study population was made up of 79 hemodialysis patients with a mean age of 53 ± 18 years (55.7% were males). These patients were divided into a normal LAVI (≤28 mL/m2) group (n = 45) and an increased LAVI (>28 mL/m2) group (n = 34). The demographic, clinical, laboratory, echocardiographic, and electrocardiographic variables of the groups were compared. RESULTS: The P wave terminal force from lead V1, P wave dispersion and PWPTs obtained from leads V1 and D2 (PWPTD2) were significantly higher in the patients with increased LAVIs. In multivariable analysis, only the PWPTD2was an independent predictor of an increased LAVI (odds ratio = 1.117, 95% CI = 1.052-1.185, p < 0.001). The receiver-operating characteristic curve analysis showed that the best PWPTD2 cutoff value for predicting an increased LAVI was 60 ms, with a sensitivity of 76.5% and a specificity of 66.7% (area under the curve = 0.736, 95% CI = 0.625-0.829, p < 0.001). CONCLUSION: This study showed that a prolonged PWPTD2 was independently associated with an increased LAVI in hemodialysis patients. Therefore, measuring the PWPTD2 duration on an electrocardiogram may help define high-risk hemodialysis patients with increased LAVIs.
No takes yet. Share an insight, caveat, or question.
Yıldız et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: